Paul B. Freeman OD, FAAO, FOVDR
Chief, Low Vision Rehabilitation Services, Allegheny General Hospital, Pittsburgh, Pennsylvania; Clinical Professor, University of the Incarnate Word, Rosenberg School of Optometry, San Antonio, TexasDr. Paul B. Freeman is the Chief of Low Vision Rehabilitation Services at Allegheny General Hospital in Pittsburgh, Pennsylvania, and he provides low vision rehabilitation services at Keystone Blind Association in Hermitage, Pennsylvania, and at Beaver County Association for the Blind in Conway, Pennsylvania. Dr. Freeman is also a Clinical Professor at the University of the Incarnate Word, Rosenberg School of Optometry in San Antonio, Texas.
Dr. Freeman’s clinical interests include visual impairment, traumatic brain injury, visual aspects of driving, and learning-related vision problems. He has been an investigator in a number of vision research projects to determine the efficacy of sophisticated low vision devices, to assess the psychological implications of low vision, and to explore the relationship of vision and the learning process.
A Fellow of the American Academy of Optometry and a Diplomate in Low Vision, Dr. Freeman is also a Fellow of Optometric Vision Development and Rehabilitation Association. He lectures both nationally and internationally and has authored numerous articles and book chapters. Currently, he is Editor-in-Chief of Optometric Clinical Practice.
Recent Contributions to PracticeUpdate:
- Comparison of Vision-Related Quality of Life and Mental Health Between Congenital and Acquired Low-Vision Patients
- Self-Reported Vision Impairment and Symptoms of Anxiety and Depression Among Older Adults
- Steroid-Induced Glaucoma and Blindness in Vernal Keratoconjunctivitis
- Comorbidity of Dementia and AMD Calls for Clinical Awareness
- Glucose Tolerance Levels and Circumpapillary Retinal Nerve Fiber Layer Thickness in a General Japanese Population
- Neurodevelopmental Outcomes Following Intravitreal Bevacizumab Therapy for Retinopathy of Prematurity
- The Port Delivery System With Ranibizumab for Neovascular Age-Related Macular Degeneration
- Association of Vision Loss With Hospital Use and Costs Among Older Adults
- Blue Light–Filtering Intraocular Lenses for Retinal Protection
- Self-Perception in Children Aged 3 to 7 Years With Amblyopia and Its Association With Deficits in Vision and Fine Motor Skills